These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Current status of pneumococcal polysaccharide immunization in patients with sickle cell disease or impaired splenic function. Ammann AJ Am J Pediatr Hematol Oncol; 1982; 4(3):301-6. PubMed ID: 7149168 [TBL] [Abstract][Full Text] [Related]
11. Cross-reacting opsonic antibodies to clinically important pneumococcal serotypes after pneumococcal vaccination. Braconier JH; Myhre EB; Odeberg H Eur J Clin Microbiol; 1983 Oct; 2(5):453-8. PubMed ID: 6641723 [TBL] [Abstract][Full Text] [Related]
12. Preimmunization and postimmunization pneumococcal antibody titers in children with recurrent infections. Hidalgo H; Moore C; Leiva LE; Sorensen RU Ann Allergy Asthma Immunol; 1996 Apr; 76(4):341-6. PubMed ID: 8612116 [TBL] [Abstract][Full Text] [Related]
13. 13-valent pneumococcal conjugate vaccine (PCV13) is immunogenic and safe in children 6-17 years of age with sickle cell disease previously vaccinated with 23-valent pneumococcal polysaccharide vaccine (PPSV23): Results of a phase 3 study. De Montalembert M; Abboud MR; Fiquet A; Inati A; Lebensburger JD; Kaddah N; Mokhtar G; Piga A; Halasa N; Inusa B; Rees DC; Heath PT; Telfer P; Driscoll C; Al Hajjar S; Tozzi A; Jiang Q; Emini EA; Gruber WC; Gurtman A; Scott DA Pediatr Blood Cancer; 2015 Aug; 62(8):1427-36. PubMed ID: 25810327 [TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up and booster immunization with polyvalent pneumococcal polysaccharide in patients with sickle cell anemia. Weintrub PS; Schiffman G; Addiego JE; Matthay KK; Vichinsky E; Johnson R; Lubin B; Mentzer WC; Ammann AJ J Pediatr; 1984 Aug; 105(2):261-3. PubMed ID: 6747758 [No Abstract] [Full Text] [Related]
16. Comparison of an opsonophagocytic assay and IgG ELISA to assess responses to pneumococcal polysaccharide and pneumococcal conjugate vaccines in children and young adults with sickle cell disease. Vernacchio L; Romero-Steiner S; Martinez JE; MacDonald K; Barnard S; Pilishvili T; Carlone GM; Ambrosino DM; Molrine DC J Infect Dis; 2000 Mar; 181(3):1162-6. PubMed ID: 10720547 [TBL] [Abstract][Full Text] [Related]
17. Serum antibody and opsonic responses after immunization with pneumococcal vaccine in kidney transplant recipients and controls. Bortolussi R; Marrie TJ; Cunningham J; Schiffman G Infect Immun; 1981 Oct; 34(1):20-5. PubMed ID: 7028628 [TBL] [Abstract][Full Text] [Related]
18. Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease. Vernacchio L; Neufeld EJ; MacDonald K; Kurth S; Murakami S; Hohne C; King M; Molrine D J Pediatr; 1998 Aug; 133(2):275-8. PubMed ID: 9709721 [TBL] [Abstract][Full Text] [Related]
19. Clinical trial of the protective role of polyvalent pneumococcal vaccine in sickle cell anaemia patients in Zambia. Chintu C; Gupta K; Osborne C; Masona JM Med J Zambia; 1983 Jul; 17(3):73-6. PubMed ID: 6679155 [No Abstract] [Full Text] [Related]
20. Serum samples from infants vaccinated with a pneumococcal conjugate vaccine, PncT, protect mice against invasive infection caused by Streptococcus pneumoniae serotypes 6A and 6B. Saeland E; Jakobsen H; Ingolfsdottir G; Sigurdardottir ST; Jonsdottir I J Infect Dis; 2001 Jan; 183(2):253-260. PubMed ID: 11110649 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]